These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9919353)

  • 1. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 4. New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues.
    Quezado ZM; Banks SM; Natanson C
    Trends Biotechnol; 1995 Feb; 13(2):56-63. PubMed ID: 7765996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive therapy for septic shock: a review of experimental approaches.
    Lynn WA; Cohen J
    Clin Infect Dis; 1995 Jan; 20(1):143-58. PubMed ID: 7727640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sepsis syndrome: progress and therapeutic perspectives].
    Schaller MD
    Schweiz Med Wochenschr; 1992 May; 122(20):768-75. PubMed ID: 1604283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis and septic shock. II. Treatment.
    Mayer J; Hajek R; Vorlicek J; Tomiska M
    Support Care Cancer; 1995 Mar; 3(2):111-9. PubMed ID: 7773578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in immunotherapy of sepsis.
    Klein DM; Witek-Janusek L
    Dimens Crit Care Nurs; 1992; 11(2):75-89. PubMed ID: 1576902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and emerging therapies for sepsis and septic shock.
    Añel RL; Kumar A
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1471-85. PubMed ID: 11772263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
    Fisher CJ; Zheng Y
    World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapies in sepsis.
    Vincent JL
    Chest; 1997 Dec; 112(6 Suppl):330S-338S. PubMed ID: 9400898
    [No Abstract]   [Full Text] [Related]  

  • 17. Conventional supportive and possible future therapy in patients affected by GITS.
    Hodler J; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):241-300. PubMed ID: 1572216
    [No Abstract]   [Full Text] [Related]  

  • 18. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.
    Natanson C; Hoffman WD; Suffredini AF; Eichacker PQ; Danner RL
    Ann Intern Med; 1994 May; 120(9):771-83. PubMed ID: 8147551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.